Latest Genous Stories
Registration study to enroll 572 patients at up to 50 study locations in Japan and US HONG KONG, May 18, 2015 /PRNewswire/ -- OrbusNeich, a global company specializing
MarketReportsOnline.com adds "Indian Coronary Stent Market Forecast to 2019" report to its research store. Dallas, TX (PRWEB) March 01, 2015
WASHINGTON, September 18, 2014 /PRNewswire/ -- The world's first and only dual therapy stent Prof. Stephen W.L.
ZWOLLE, The Netherlands, June 12, 2014 /PRNewswire/ -- Randomized Evaluation of short-term DUal antiplatelet therapy in patients with acute coronary syndrome treated with
COMBO(TM) Dual Therapy Stent shown to actively promote rapid endothelialization and deliver long-term, true vessel healing HONG KONG, May 23, 2014 /PRNewswire/ --
HONG KONG, April 24, 2014 /PRNewswire/ -- OrbusNeich today announced the appointment of B.
Post-Market Registry to Evaluate Long-Term Safety and Performance in Routine Practice HONG KONG, March 28, 2014 /PRNewswire/ -- OrbusNeich today announced the completion of enrollment
-- Rapid polymer absorption within three months coupled with drug delivery profile up to nine months provides for excellent healing -- DURHAM, N.C., March 5, 2014 /PRNewswire/ ---
Company Initiates Joint U.S. and Japanese Registration Trial HONG KONG, Feb.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.